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RESEARCH ARTICLE
The Potential for a Blood Test for Scabies
Larry G. Arlian1*, Hermann Feldmeier2, Marjorie S. Morgan1
1 Department of Biological Sciences, Wright State University, Dayton, Ohio, United States of America,




Scabies afflicts millions of people worldwide, but it is very difficult to diagnose by the usual
skin scrape test, and a presumptive diagnosis is often made based on clinical signs such as
rash and intense itch. A sensitive and specific blood test to detect scabies would allow a
physician to quickly make a correct diagnosis.
Objective
Our objective was to profile the mite-specific antibodies present in the sera of patients with
ordinary scabies.
Methods
Sera of 91 patients were screened for Ig, IgD, IgE, IgG and IgM antibodies to S. scabiei, as
well as to the house dust mites Dermatophagoides farinae, D. pteronyssinus and Eurogly-
phus maynei.
Results
45%, 27% and 2.2% of the patients had measurable amounts of mixed Ig, IgG and IgE that
recognized scabies mite antigens. However, 73.6% of the scabies patients had serum IgM
that recognized scabies proteins, and all except two of them also had IgM that recognized
all of the three species of dust mites. No patient had serum antibody exclusively reactive to
scabies mite antigens.
Conclusions
Co-sensitization or cross-reactivity between antigens from scabies and house dust mites
confounds developing a blood test for scabies.
Author Summary
Scabies, caused by the mite S. scabiei that burrows in the skin of humans, is a contagious
skin disease that affects millions of people worldwide. It is a significant public health
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burden in economically disadvantaged populations, and outbreaks are common in
nursing homes, daycare facilities, schools and workplaces in developed countries. It
causes significant morbidity, and in chronic cases, associated bacterial infections can
lead to renal and cardiac diseases. Scabies is very difficult to diagnose by the usual skin
scrape test, and a presumptive diagnosis is often made based on clinical signs such as
rash and itch that can mimic other skin disease. A sensitive and specific blood test to
detect scabies-specific antibodies would allow a physician to quickly make a correct
diagnosis. Our manuscript reports the antibody isotype profiles of the sera of two groups
of patients with ordinary scabies (17 from the US and 74 from Brazil) and concludes
that such a blood test should be based on circulating IgM type antibodies that do
not also recognize antigens of the related and ubiquitous house dust mites. Both are
important considerations for research for developing a blood test for the diagnosis of
scabies.
Introduction
Scabies, caused by the mite, Sarcoptes scabiei, is a worldwide-occurring parasitic skin disease
[1, 2]. It was recently added to the list of neglected tropical diseases by the World Health
Organization [3]. Estimates of the prevalence of scabies range from a small percent of the pop-
ulation in developed countries to high prevalence in some resource-limited communities in
countries of the global south where the disease may affect up to 50% of women and children
[4–13]. In addition, outbreaks are reported in nursing homes and daycare facilities (among
both workers and clients), as well as in kindergartens, hostels, schools, among colleges stu-
dents, and in work environments where there is much physical contact between individuals
[14–18].
Ordinary—in contrast to crusted—scabies is very difficult to diagnose. Parasitological
techniques are rather insensitive and clinically scabies can mimic other skin diseases such as
eczema, psoriasis, atopic dermatitis, diaper rash, poison ivy dermatitis and skin reactions to
irritating agents such as soaps/detergents, metals, and lotions. A presumptive diagnosis of
scabies requires confirmation by recovering mites, mite fecal pellets, and eggs from the
corneal layer of the epidermis. In practice though, patients are often diagnosed with
scabies based on clinical characteristics such as a rash and intense itch. Since none of the
symptoms and signs are pathognomonic, this approach frequently results in a false-positive
diagnosis, which in turn exposes the patient to a potentially hazardous treatment. In con-
trast, crusted scabies (also known as “Norwegian scabies”) is easily recognizable by the
hyperkeratosis that manifests with a scaly and thickened (i.e., crusted) strateum corneum
and accompanying large mite burden as compared to the low mite burden and rash of ordi-
nary scabies.
A sensitive and specific blood test to detect scabies-specific circulating antibodies would
allow a physician to quickly make a correct diagnosis. One of the problems with developing
such a test is that many of the antigens from scabies mites cross-react with antigens from the
common allergy-causing house dust mites, Dermatophagoides farinae, D. pteronyssinus and
Euroglyphus maynei that occur worldwide [19–22]. We report here the antibody isotype pro-
files of the sera of two groups of patients with ordinary scabies (from Brazil and the United
States) that recognize scabies and house dust mite antigens and illustrate the confounding
problem of cross-reactivity and cross-sensitization.
Scabies Diagnostic Test
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Methods
Ethics statement
Serum from the US patients (17 subjects + positive reference) was collected under Human Sub-
jects Protocol (HSP) #0205 as approved by the Wright State University Institutional Review
Board (IRB). Negative control sera were previously provided to us without personal identifiers
under protocol SC #2714 approved as EXEMPT under CFR 46.101(b)(4) by the Wright State
University IRB.
Serum from the Brazilian patients was provided to Wright State researchers without per-
sonal identifiers. The research was approved as EXEMPT under CFR 46.101(b)(4) and was
approved under protocol SC #4334 by the Wright State University IRB. The original study was
approved by Universidade Federal do Céara—Comité de Ética em Pesquisa, protocol 358/08.
The text of the consent form was read out loud in the presence of other household members
(for both children and adults) and the collection procedures and subsequent laboratory tech-
niques were explained in plain language. All adult subjects and guardians of minor children
then signed the consent forms that had been read to them.
Human sera
Sera were obtained following consent from two groups of patients with ordinary scabies at the
time of initial diagnosis. Sera were collected from patients at a dermatologist’s office in Cincin-
nati, OH, USA. This group was composed of 17 subjects (6 females + 11 males, 18–72 yrs of
age) who had ordinary scabies confirmed by the recovery of live mites by skin scraping at the
time of diagnosis and who reported having had symptoms for 0–13 months prior to diagnosis.
Sera were also collected from 74 scabies patients (44 females + 30 males, 5–73 yrs of age) in a
resource-poor community in Fortaleza, Northeast Brazil. These patients were identified by
active case detection. The clinical diagnosis was confirmed by dermoscopy and skin scraping
and 86.3% of the patients had 3 or more topographic areas affected. In 42.1% the duration of
the infestation was< 3 weeks.
As a positive reference, serum previously collected from an ordinary scabies patient was
used. This 72 yr old male who presented at a dermatologist’s office in Dayton, OH reported
having had scabies symptoms for> 4 yrs. His serum had previously been demonstrated to con-
tain high levels of circulating antibody to scabies [23] and radioallergosorbent testing (RAST;
conducted by Clinical Immunology and Allergy, Liberty, MO) showed total IgE> 1000 U/mL
and modified RAST class 2 scores (scores range from 0 to 6) for specific IgE to both D. farinae
and D. pteronyssinus. A pool of negative control sera was prepared by mixing equal volumes of
serum from two individuals that had no known history of scabies and that had previously been
demonstrated to have low levels of circulating antibody to extracts of any of 9 astigmatid mite
species [24, 25].
Mite extracts
Aqueous extracts were prepared from Sarcoptes scabiei var. canis and from the house dust
mites Dermatophagoides farinae, D. pteronyssinus, and Euroglyphus maynei according to our
standard protocol. Briefly, scabies mites were collected by aspiration onto a 38 μm stainless
steel mesh (Small parts, Inc., Miami Lakes, FL) after they had migrated from crusts. To remove
host material, live mites were washed by drawing sequential 4 mL aliquots of PBST (Dulbecco’s
Phosphate Buffered saline with 0.05% Tween 20), endotoxin-free water and 70% ethanol
through the mesh. Mites were killed by freezing at -80°C where they were stored until used.
Scabies Diagnostic Test
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Dust mites were collected by aspiration as they migrated from cultures, killed by freezing,
lyophilized and stored at -20°C until used. Mites of each species were suspended in endotoxin-
free water (at 1:10 W:V for dust mites and 1:20 W:V for scabies mites) for overnight extraction
at 4°C. The next day, samples were ground 10 strokes on ice using a TenBroeck homogenizer,
the insoluble material was removed by centrifugation for 10 min at 14 k x g and the superna-
tants were sterile filtered into sterile vials. To extract as much protein as possible, the scabies
mite pellet was subjected to a second extraction/homogenization/centrifugation and the two
supernatants were combined. Protein content in each extract was determined by the method of
Bradford [26] using bovine serum albumin (BSA) as the standard.
Enzyme-linked immunosorbent assays (ELISAs)
Microtiter plates for each mite extract were coated with 0.5 μg protein/well in 50 mM carbon-
ate/bicarbonate buffer, pH 9.6, and allowed to dry. Plates were made in two batches (one for
each serum cohort) and were stored in a desiccator at room temperature until used. Before use
and between all steps, plates were washed with PBST. Plates were blocked with 1% BSA in
PBST and loaded with 100 μL of serum diluted 1/10 (IgD and IgE) or 1/1000 (Ig, IgG and
IgM). All samples were loaded in duplicate wells and each plate had a parallel set of positive
a4nd negative control sera.
Serum antibody binding was detected using biotinylated antibodies specific for human
mixed Ig [IgM+IgG+IgA, H+L], IgD [δ chain specific], IgE [specific for Fc portion of the heavy
chain], IgG [γ chain specific], or IgM [μ chain specific] (all diluted 1/5000) followed by strepta-
vidin-peroxidase (1/5000). All were purchased from Southern Biotech (Birmingham, AL).
Plates were developed with 100 μL of 1 mM ABTS in 70 mM citrate phosphate buffer, pH 4.0,
with 0.03% hydrogen peroxide. Development was stopped by the addition of 50 μL of 0.2%
sodium azide and plates were read immediately.
To account for plate-to-plate variability, all data were normalized at the conclusion of the
study. For each antibody class and antigen, the 405 nm absorbances of all the wells for the posi-
tive control serum were averaged. These values were then used, along with the controls for
each individual plate, to calculate normalized ELISA absorbance values for each serum/anti-
body class/antigen.
Results
For this study, the negative control serum used was a pool of individuals that had previously
been determined to lack circulating antibodies that recognized antigens present in extracts of
scabies, house dust and stored product mites [24, 25]. A positive titer to any mite extract was
defined as an ELISA absorbance of at least 2 times that of the negative controls for mixed Ig
and IgG or exceeding 0.100 for IgM or 0.050 for IgE. The positive reference serum was from a
single patient that had scabies for more than 4 years and that had previously been determined
to have high levels of antibodies to scabies and Dermatophagoidesmites.
ELISA analysis of the serum from 91 scabies patients showed that 45.1% had circulating
antibody (Ig) that bound to scabies antigens (Table 1). This included 6 of the 17 patients from
the US (35%) and 35 of the 74 patients from Brazil (47%). Of all the 91 patients, 27.5% and
73.6% had measurable levels of serum IgG and IgM antibody, respectively, that bound to sca-
bies proteins (Table 1). Serum IgM levels to scabies were higher for the Brazilian patients than
for the US subjects while their Ig and IgG levels were similar (Fig 1). Notably, the average IgM
binding to scabies antigens by the Brazilian patients resulted in ELISA absorbances that were
more than twice those exhibited by US patients. Only 2 of the scabies patients (2.2%), both Bra-
zilians, had circulating IgE antibodies that bound to scabies proteins and both of these gave
Scabies Diagnostic Test
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Table 1. Number and percentage of the 91 ordinary scabies patients with serum antibody that recognized scabies and house dust mite antigens
by ELISA.
Antibody Class Serum Dilution Target antigen on the ELISA plate
S. scabiei D. farinae D. pteronyssinus E. maynei
Ig 1/1000 # (+) 41 80 81 84
% (+) 45.1% 87.9% 89.0% 92.3%
IgG 1/1000 # (+) 25 77 83 79
% (+) 27.5% 84.6% 91.2% 86.8%
IgM 1/1000 # (+) 67 69 76 77
% (+) 73.6% 75.8% 83.5% 84.6%
IgE 1/10 # (+) 2 3 2 3
% (+) 2.2% 3.3% 2.2% 3.3%
A positive titer to any mite extract was defined as an ELISA absorbance of at least 2 times that of the negative controls for mixed Ig and IgG or exceeding
0.100 for IgM or 0.050 for IgE.
doi:10.1371/journal.pntd.0004188.t001
Fig 1. Mixed Ig, IgG and IgM serum antibody binding to ELISA plates coated with scabies or house dust mite antigens.Data are presented as the
mean ELISA absorbance ± standard error of the mean for sera collected from ordinary scabies patients in the US (n = 17) and Brazil (n = 74).
doi:10.1371/journal.pntd.0004188.g001
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very low absorbance readings (0.070 and 0.073). No patient had measurable levels of serum
IgD directed at the antigens of any mite.
All except two of the 67 patients that had serum IgM antibodies to scabies antigens also had
IgM that recognized all of the three species of dust mites, D. farinae, D. pteronyssinus, and E.
maynei. Of the 25 scabies patients with IgG to scabies, 24 also had IgG to all three dust mite
species. No patient had serum antibodies exclusively reactive to scabies mite antigens.
The Brazilian patients had substantially higher levels of serum IgM recognizing antigens of
all four mite species than did the US cohort (Fig 1). Although IgG binding to scabies proteins
was the same for the two groups, IgG binding to each of the dust mite extracts was higher for
the Brazilian cohort than for the US group. No difference between the groups was observed for
Ig binding to any of the mite extracts.
US patients
Among the 17 US patients, 10 had IgM, 6 had IgG and 6 had Ig that recognized scabies mite
antigens. Five patients with elevated IgM antibodies to scabies antigens did not have elevated
IgG or mixed Ig to scabies. Conversely, 3 patients had elevated IgG antibodies to scabies but
not elevated IgM and 3 patients did not show any antibody binding to scabies mite proteins.
No US patient had detectable levels of IgE to scabies mites.
While not all of the US patients had circulating antibody that bound to scabies antigens, all
did have elevated levels of at least one antibody class that recognized antigens of the house dust
mites D. farinae, D. pteronyssinus, and E.maynei. All 6 patients with Ig to S. scabiei also had Ig
to D. farinae, D. pteronyssinus, and E.maynei. There was also no IgE binding detected to any of
the house dust mite extracts.
Brazil patients
Among the 74 Brazilian patients, 57 had IgM and 19 had IgG that recognized scabies antigens
while 35 patients had elevated mixed Ig to scabies. Of the 57 patients that had elevated IgM to
scabies, 23 did not have elevated IgG or mixed Ig to scabies antigens. Two of the Brazilian
patients had detectable levels of IgE to scabies antigens. Eight of the scabies patients had no
detectable circulating antibody binding to scabies antigens.
With the exception of one patient that showed no antibody binding to D. pteronyssinus, all
Brazilian patients had Ig, IgG and/or IgM that bound to antigens of all three house dust mite
species. Of the 57 patients that had elevated IgM to scabies all except one also had elevated IgM
to D. farinae, D. pteronyssinus and E.maynei. Likewise, of the 19 patients that had elevated IgG
to scabies all also had elevated IgG to all three dust mites. Of the 35 patients with mixed Ig that
recognized scabies mite antigen, all but two also had Ig that recognized antigen of all three spe-
cies of dust mites.
Discussion
Although scabies mites burrow and reside in the stratum corneum of the epidermis, historical
studies along with more recent studies clearly indicate that antigens from scabies mites induce
a humoral response in the host. Thus, theoretically it may be possible to develop a blood test
for scabies based on circulating antibodies that recognize scabies-specific antigens that do not
cross-react with house dust mites. We provide a brief history of studies profiling information
that leads to the conclusion that scabies can be diagnosed with a simple blood test but that the
antigens will need to be carefully selected.
Some early studies reported highly diverging results concerning total serum IgG, IgA, and
IgE, and complement C3 and C4 levels in scabies patients compared to control subjects without
Scabies Diagnostic Test
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scabies [27–31]. None of these studies directly investigated whether or not the altered serum
immunoglobulin isotype levels were the result of scabies infestation and were specific to scabies
mite antigens. Hence, these studies do not allow any conclusion.
Several studies indirectly associated serum antibody concentrations to scabies infestation.
These studies showing a relationship between changes in antibody isotype levels during scabies
infestation compared to those following successful treatment suggested a cause-and-effect asso-
ciation with scabies infestation although the presence of specific antibodies to scabies antigens
were not determined [28, 32, 33]. However, it was not excluded that the scabies patients were
concomitantly infected with helminths and that the presence of helminths caused the immuno-
logical alterations.
More recent studies using S. scabieimite extract or recombinant scabies molecules prepared
from mites collected from different host species clearly showed that animal and human hosts
build antibodies to specific S. scabieimolecules [21, 23, 34–42]. Two studies showed that
human patients with crusted scabies had elevated total scabies-specific IgE compared to those
with ordinary scabies [35, 43]. Walton et al. [43] found that subjects with both ordinary and
crusted scabies had elevated antibody levels specific for several recombinant scabies antigens
compared to naïve control subjects never exposed to scabies. Additionally, an immunoassay
employing a recombinant scabies protein, rSar s 14.3, that corresponds to residues 1263–1655
of the dust mite allergen Der p 14, showed significantly higher IgE binding by plasma from
crusted scabies patients than from ordinary scabies patients [44]. The IgE binding by the ordi-
nary scabies patients was also significantly higher than that of controls and no cross-reactivity
with the dust mite homolog was observed.
Obtaining sufficient amounts of human scabies mites for research purposes is very difficult.
However, use of mites collected from dogs, pigs, and foxes as a source of material for research
to develop a diagnostic test and vaccine for human scabies offers a promising alternative. It is
not clear if S. scabieimites from such hosts are the same species or only subtle genetic variants
because S. scabieimites from most different host species are morphologically indistinguishable.
The most recent molecular study indicated that mites collected from humans could be distin-
guished from those collected from animals based on sequencing of the 317-bp mtDNA cox1
gene but not when several other molecular markers were used [45]. This analysis also suggested
that all the mites collected from various animal hosts were monospecific while the mites iso-
lated from humans from different geographical locations clustered into four separate branches
representing four different species [45].
More importantly, several studies have shown that there is significant antigenic cross-reac-
tivity between different strains of scabies mites from different hosts but there are also strain-
specific antigens [23, 46]. For example, S. scabiei var. suis from pigs, var. canis from dogs and
var. hominis from humans share cross-reacting antigens. Likewise, humans with scabies have
circulating antibodies that recognize antigens from S. scabiei var. vulpis from foxes, var. canis,
and var. suis [23, 46]. Haas et al. [46] found that 48% of scabies patients had IgG that recog-
nized antigens from fox mites and patients with greater severity and duration of scabies had
significantly higher IgG titers. In addition, Western blotting showed that a 72-year-old male
with chronic scabies had IgG that recognized more than 10 antigens from S. scabiei var. canis
[23]. Also, serum from 6 patients with crusted scabies had IgE to 11–21 and IgG to 1–7 anti-
gens from S. scabiei var. canis but patients with ordinary scabies had serum IgG and IgE that
recognized many fewer antigens [35]. And a crude whole body extract of S. scabiei var. vulpes
obtained from red foxes contained antigens recognized by antibodies in serum from scabies
infested pigs [47] and chamois [48]. An ELISA using the recombinant Ssλ20ΔB3 antigen
from S. scabiei var. hominis detects serum antibody in Iberian red deer, Southern chamois,
pigs, and rabbits infected with sarcoptic mange [49–53]. Likewise, several recombinant
Scabies Diagnostic Test
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proteins generated from S. scabiei var. suis were recognized by antibodies in sera of human
patients infected with S. scabiei var. hominis [54]. Therefore, using mites collected from various
host species provides a means of identifying specific molecules and antibody isotypes that may
be useful in developing a diagnostic test for scabies and overcomes the problem of a limited
supply of var. hominismites.
The present study using a canine strain of scabies to prepare antigen for use in ELISA,
found that only 45%, 27% and 2.2% of 91 patients with ordinary scabies had measurable
amounts of mixed Ig, IgG and IgE that recognized scabies mite antigens, respectively. No
patient had IgD that recognized scabies mite antigen. However, 73.6% of the scabies patients
had serum IgM that recognized S. scabiei antigens with substantially higher levels observed
from the Brazilian patients compared to those from the US. This suggests that the Brazilian
patients were diagnosed rather early in the infestation since they had not switched to IgG pro-
duction that follows an initial IgM response. Conversely, the observation that more patients
had IgG to the house dust mites suggests a more chronic exposure to these mites. Based on
these results, it appears that a diagnostic test should be based on detecting serum IgM to scabies
antigens. Such a test would be beneficial because IgM is the first antibody class produced,
before class switching to IgG occurs, so it may allow for earlier diagnosis of scabies. The differ-
ences between the responses of the two groups of patients may reflect differences in the strains/
species of scabies mites infesting these geographically-distant patients as suggested by the Zhao
et al. study [45].
This study again elucidates the problem of co-sensitization or cross-reactivity between anti-
gens from house dust mites that confounds developing a blood test for scabies. House dust
mites are the sources of> 25 antigenic proteins [55]. Many of the antigens from house dust
mites cross-react with those from scabies mites [19–22]. Also a significant percentage of people
are sensitized to the ubiquitous house dust mites, D. farinae, D. pteronyssinus and E.maynei.
Every scabies patient of this study except one had circulating Ig, IgG, and/or IgM to all three
house dust mite extracts and no scabies patient had antibodies exclusively to scabies mites.
Thus, the key to a diagnostic test that possesses both specificity and sensitivity likely lies in
identifying a limited and defined set (used as a cocktail) of scabies proteins (or protein frag-
ments) that do not carry epitopes that cross-react with those on house dust mite proteins and
that bind IgM from the serum of scabies patients. To accomplish this goal, a detailed and com-
prehensive proteomic and genomic analysis of S. scabiei is necessary.
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